S

Satellos Bioscience Inc
XTSX:MSCL

Watchlist Manager
Satellos Bioscience Inc
XTSX:MSCL
Watchlist
Price: 0.56 CAD 1.82% Market Closed
Market Cap: 56.2m CAD

Net Margin
Satellos Bioscience Inc

0%
Current
0%
Average
-6.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-16.1m
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

Satellos Bioscience Inc
Glance View

Market Cap
56.2m CAD
Industry
Biotechnology

Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. The company is headquartered in Toronto, Ontario. The company went IPO on 2006-12-01. The firm is engaged in developing therapeutics that stimulate or restore muscle regeneration in severe disorders. Its lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct dysregulated muscle stem-cell polarity, which balances replenishment of muscle stem cells and production of specialized tissue cells. The company uses MyoReGenXTM discovery platform to identify regulatory pathways and drug candidates to treat muscle disorders. The company also maintains two clinical stage products: iCo-008 for potential use in eotaxin-1 mediated indications and an oral Amphotericin B delivery system. iCo-008 provides treatment of the dermatological condition bullous pemphigoid (BP), atopic dermatitis, gastrointestinal conditions, and age-related macular degeneration (AMD). Oral Amphotericin B delivery system provides treatment of Visceral Leishmaniasis (VL).

MSCL Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-16.1m
/
Revenue
0
What is the Net Margin of Satellos Bioscience Inc?

Based on Satellos Bioscience Inc's most recent financial statements, the company has Net Margin of 0%.

Back to Top